Medtronic's CoreValve system today gained a second indication from the FDA for use in patients with severe aortic stenosis who are at high risk for surgery. The transcatheter aortic valve replacement ...

MINNEAPOLIS – Medtronic, Inc.today announced it has received CE (Conformité Européenne) Mark for the Medtronic CoreValve® System to be delivered using direct aortic access. The Medtronic CoreValve ...

Medtronic Inc. announced Tuesday that its CoreValve System, designed to enable the replacement of a diseased aortic valve without open heart surgery, showed health improvements over a two-year period ...

Siegburg, Germany - Percutaneous implantation of the self-expanding CoreValve aortic valve bioprosthesis in the first-ever series of patients shows that the procedure is feasible in those deemed too ...

FRESNO, Calif. (KFSN) -- Severe aortic stenosis is a heart condition that happens when the aortic valve doesn't open properly. Patients used to have to undergo an invasive, open-heart surgery to ...

The FDA today approved Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis who are unable to undergo conventional open-heart surgery.

Medtronic ($MDT) said that its recent CE mark for its CoreValve Evolut R System for transcatheter aortic valve implantation (TAVI) paves the way for the option to ...

In a clinical trial, a self-expanding transcatheter aortic valve met the key performance objective of reducing death and stroke in patients with severe aortic stenosis at "extreme risk" for ...

Medtronic says it plans to appeal the $73.5 million jury verdict that its CoreValve transcatheter aortic valve system infringes a U.S. Andersen patent owned by Edwards Lifesciences. The CoreValve ...